IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,531,044 | -40.5% | 239,600 | +77.6% | 0.22% | +317.0% |
| Q4 2021 | $2,575,000 | -53.8% | 134,900 | -40.3% | 0.05% | -68.6% |
| Q3 2021 | $5,574,000 | +167.7% | 226,000 | +182.5% | 0.17% | +128.4% |
| Q2 2021 | $2,082,000 | +31.5% | 80,000 | +60.0% | 0.07% | +85.0% |
| Q1 2021 | $1,583,000 | -86.5% | 50,000 | -80.2% | 0.04% | -82.1% |
| Q4 2020 | $11,739,000 | +17.7% | 253,000 | -16.5% | 0.22% | -39.6% |
| Q3 2020 | $9,975,000 | +372.5% | 303,000 | +294.0% | 0.37% | +152.7% |
| Q2 2020 | $2,111,000 | +1307.3% | 76,900 | +1438.0% | 0.15% | +630.0% |
| Q1 2020 | $150,000 | – | 5,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 11,997,103 | $84,459,605 | 11.88% |
| MPM BioImpact LLC | 2,950,118 | $20,768,831 | 4.18% |
| Perceptive Advisors | 14,036,410 | $98,816,326 | 2.86% |
| Velan Capital Investment Management LP | 240,000 | $1,689,600 | 1.57% |
| Parametrica Management Ltd | 96,500 | $679,360 | 1.31% |
| Boxer Capital, LLC | 3,705,133 | $26,084 | 1.21% |
| Soleus Capital Management, L.P. | 1,239,777 | $8,728,030 | 0.97% |
| Opaleye Management Inc. | 421,000 | $2,963,840 | 0.71% |
| 683 Capital Management, LLC | 1,400,000 | $9,856,000 | 0.71% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,758,759 | $12,381,665 | 0.70% |